KFI
LFCR icon

Key Financial Inc’s Lifecore Biomedical LFCR Stock Holding History

Key Financial Inc’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.17K Hold
1,120
– – ﹤0.01% 1070
2025
Q4 		$9.16K Hold
1,120
– – ﹤0.01% 907
2025
Q3 		$8.03K Hold
1,120
– – ﹤0.01% 938
2025
Q2 		$9.09K Buy
+1,120
New +$7.55K ﹤0.01% 878
2024
Q2 		– Sell
-1,120
Closed -$5.95K – 1363
2024
Q1 		$5.95K Hold
1,120
– – ﹤0.01% 894
2023
Q4 		$6.93K Hold
1,120
– – ﹤0.01% 832
2023
Q3 		$8.45K Hold
1,120
– – ﹤0.01% 760
2023
Q2 		$10.8K Hold
1,120
– – ﹤0.01% 699
2023
Q1 		$4.23K Sell
1,120
-2,145
-66% -$12K ﹤0.01% 843
2022
Q4 		$29K Hold
3,265
– – 0.01% 438
2022
Q3 		$29K Hold
3,265
– – 0.01% 442
2022
Q2 		$33K Hold
3,265
– – 0.02% 427
2022
Q1 		$38K Hold
3,265
– – 0.02% 395
2021
Q4 		$36K Hold
3,265
– – 0.02% 394
2021
Q3 		$30K Hold
3,265
– – 0.02% 409
2021
Q2 		$36K Buy
+3,265
New +$37.6K 0.02% 393

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Key Financial Inc's LFCR Position: Q1 2026 in Review

Key Financial Inc held its Lifecore Biomedical (LFCR) position steady in Q1 2026 at 1,120 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Key Financial Inc first reported a position in LFCR in Q2 2021 and has held it in 16 quarters since. The position peaked at $38K in Q1 2022. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • Key Financial Inc held 1,120 shares of Lifecore Biomedical worth $4.17K as of Q1 2026.
  • Key Financial Inc left its Lifecore Biomedical share count unchanged in Q1 2026.
  • Lifecore Biomedical made up ﹤0.01% of Key Financial Inc's portfolio in Q1 2026, its #1070 holding.
  • Key Financial Inc first reported a position in Lifecore Biomedical in Q2 2021 and has held it in 16 quarters since.
  • Key Financial Inc's Lifecore Biomedical position peaked at $38K in Q1 2022.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.